| Ytd | 22.26% | |
| 1y | 488.57% |
| Open | 4.14 | Prev Close | 4.21 | Low | 4.06 | High | 4.29 | Mkt Cap | 678.21M |
| Vol | 1.65M | Avg Vol | 2.29M | EPS | 0.62 | P/E | 6.65 | Forward P/E | 12.08 |
| Beta | 0.47 | Short Ratio | 6.73 | Inst. Own | 105.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.85 | 200-d Avg | 3.38 | 1yr Est | 12.50 |
IRWD News
Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art
Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr
– Expanded indication extends availability to children ages 2-5 with FC; previously approved in pedi
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 m
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which met the
Surveyed HCPs emphasized the importance of reducing patient dependence on TPN to improve quality of
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV
Citizens analyst Jason N. Butler maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market O
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 m
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.01) per share which missed t
Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-We
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were update
Ironwood Pharmaceuticals (IRWD) stock rose with high volume on Friday, releasing financial guidance
Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-We
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2025 sales outlook from $260.000 million-$290.000 mi
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which beat the
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-1st-drug-children-7-years-and-older-i
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futur
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Monday's session saw 175 companies set new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.